Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.

PLoS One · 2013 · PMC3680460 · PMID 23776502

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A network analysis identified numerous highly significant networks with a score ≥3 that were down- or up-regulated in HepG2 and Huh7 cells upon combined SOR+CLX treatment.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.